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CHAPTER 2 
 
LITERATURE REVIEW 
 
 2.1 Overview on bone 
   Bone is a dynamic organ that put together part of the endoskeleton of 
vertebrates. It is produced by the deposition of minerals in our body. Bone has a 
different organization of structures at a different length scales which work to 
perform various function such as structural support, protection and storage of 
healing cells, and mineral ion homeostasis (Liu and Webster, 2007). 
Bone can be divided into three levels of structure depending on the size: 
1. The nanostructure such as non-collagenous organic proteins, 
fibrillar collagen and mineral crystals. 
2. The microstructure such as lamellae, osteons and Haversian 
systems. 
3. The macrostructure such as cancellous and cortical bone. 
  
2.1.1 Nanostructure of bone 
The component of this hierarchical architecture level is the building blocks 
of bone which composed of both organic compounds and inorganic compounds. 
The main structures observed at this level would be the collagen fibers which are 
surrounded and infiltrated by minerals. The exact composition of bone varies 
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depending on factors such as species, age, dietary profile, health status and the 
location of the bone.  
Almost 90 % of the organic phase is made up of Type I collagen while the 
remaining is made up of noncollagenous proteins and ground substances. Type I 
collagen is synthesized by osteoblasts. The linear molecules of Type I collagen 
are self-assembled in the form of triple helix bundles with a specific periodicity 
and gaps which are called hole-zones situated between the ends of the molecules 
and also between the sides of the parallel molecules. These fibers accommodate 
the framework and architecture of bone. Hydroxyapatite (HA) crystals can be 
found located between the fibers. 
On the other hand, non-collagenous proteins, bone inductive proteins and 
extracellular matrix compounds made up the 10% of the organic phase. Non-
collagenous proteins are produced by osteoblasts during new bone formation. At 
the same time, calcium and phosphate ions are deposited in between the hole-
zones and pores of the collagen matrix to promote the growth of HA crystals. 
Despite the small percentage of contribution to the overall weight of the bone, 
they have major contributions to bone’s function. Nevertheless, the ground 
substances can be found filling up the spaces between the collagen fibers and HA 
crystals. 
The HA crystals is the inorganic component of bone. As mentioned earlier 
on, it is located between the collagen fibers. The location of these crystals limits 
the possible growth of mineral crystals, forcing it to be discrete and 
discontinuous. The size of these crystal plates are approximately 50 × 25 nm and 
the thickness is about 2-3 nm ( Rho et al., 1998 ). Small amount of impurities may 
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be present in the mineralized HA matrix. These impurities might affect the 
cellular functions of bone such as altering certain physical properties of bone and 
important biological aspects which are crucial for normal function of the bone 
(Liu and Webster, 2007). 
 
2.1.2 Microstructure of bone 
Bone consists of two main structures in this level. They are woven and 
lamellae. Woven bone is located in the metaphyseal region of growing bone, in 
fracture callus and in diseased bone. Woven bone is in a disorganized structure 
and it is made up of disoriented coarse collagen fibers, but forms quickly. 
Lamellae bone is the resultant of remodelling of woven bone or existing 
bone. It is stronger and highly organized. It is filled with collagen fibers which lie 
in parallel in each lamella and this explained the properties of having a great 
strength which is parallel to the longitudinal axis of the collagen fibers. Lamellae 
bone forms concentric rings called osteons with a central blood supply known as 
the Haversian system (Liu and Webster, 2007).  
 
2.1.3 Macrostructure of bone 
At this level, bone is divided into two types: cortical bone or compact bone 
and cancellous bone or spongy bone. Cortical bone is densely packed (less than 
30% porosity) and is composed of small pores up to 1 mm in diameter. It covers 
about 80 % of all skeletal tissue and it has a structural form suitable to withstand 
stress. The cortical bone surrounds the cancellous bone, which is made up of 
intermeshing thin, bony plates that fill the bony cavities and are in contact with 
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the bone marrow. Cancellous bone exposes a large area to the body fluid. It is 
characterized by a sponge-like branching network structure with 50 to 90 % 
porosity and large pores with the size of several millimetres in diameter. 
Cancellous bone is more active and thus it shares a greater extent than cortical 
bone by changes in skeletal metabolism (Liu and Webster, 2007).  
 
2.2 Bone cells and bone remodelling 
Bone being a dynamic organ has the ability to regenerate when damaged 
and to remodel when the loading condition change. Therefore the definition of 
bone remodelling can be best described as the process of resorption followed by 
replacement of bone with minimal physical changes in respond to different kinds 
of stress produced by physical activity or mechanical loads throughout a life span. 
The fundamental purpose of bone remodelling is to regulate calcium homeostasis, 
repair micro damaged bones and also to shape and sculpture the skeleton frame 
during growth.  
The process of bone remodelling is activated through the formation of a 
bone-modeling unit which consists of three types of bone cells which are 
osteoblast, osteoclasts and osteocytes. Osteoclasts are responsible to break down 
old calcified bone in the process of bone resorption. They are activated by growth 
factors, cytokines and proteins present in the bone matrix. On the other hand, the 
function of osteoblasts is to produce bone matrix when mineral is added to form 
calcified bone. These bone cells are activated by growth factors such as insulin-
like growth factors I and II released by both osteoclasts and/or osteocytes. 
Osteocytes are found within the confines of bone rather than on the surface and 
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they commence the process of bone calcification by modulating osteoblast 
differentiation from non-calcium depositing to calcium depositing cells through 
the released of growth factors such as insulin-like growth factor I and the tissue 
growth factor β (Liu and Webster, 2007).   
 
2.2.1 Osteoblasts 
 Osteoblasts arise from osteoprogenitor cells located in the periosteum and 
the bone marrow. They can be found on the periosteal and endosteal surfaces of 
bone. The estimated size range of an osteoblast cell is from 10 to 50 μm in 
diameter. Osteoblasts are responsible for new bone formation. During 
osteogenesis, osteoblasts which are differentiated from osteoprogenitor cells, 
proliferate actively and express genes for Type I collagen, vitronectin and 
fibronectin. Extracellular matrix begins to develop and mature during the end of 
proliferation while osteoblasts start to differentiate to calcium depositing cells. 
The synthesis of osteopontin, collagenase (mRNA expression for proteins) and 
alkaline phosphatase activity increased rapidly. When the mineralization process 
begins, osteoblasts are formed and deposit bone sialoprotein, osteocalcin and other 
matrix protein. Osteocalcin interacts with HA to mediate coupling to bone 
resorption by osteoclasts and bone formation by osteoblasts and osteocytes (Liu 
and Webster, 2007).  
 
2.2.2  Osteocytes 
 An osteocyte, a star-like shaped cell is derived from matured osteoblasts 
trapped in the mineralized bone matrix. It implements a smaller contribution to 
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new bone formation compared to osteoblast. Osteocytes which possess extensive 
long branches are networked to each other via long cytoplasmic extensions that 
occupy tiny canals called canaliculi, which are used for exchange of nutrients and 
waste. Osteocytes have the ability to control the vascular invasion and osteoclast 
recruitment during bone remodelling by secreting vascular induction factors in 
response to ischemic conditions. Osteocytes activate a specific gene for 
osteopontin- an important factor for mediating bone remodelling caused by 
mechanical stress (Roberts and Hartsfield, 2004). This mechanism controls the 
bone remodelling by mediating or balancing, either osteoblastic activity to form 
new bone or osteoclastic activity to dissolve old bone (Liu and Webster, 2007).  
 
2.2.3  Osteoclasts 
 Osteoclasts are derived from preosteoclasts which circulate in the blood. 
These cells lie in the small cavity of the bone resorption regions called Howship’s 
lacunae. Osteoclasts are responsible for removing bone tissues by removing its 
mineralized matrix. They come in rather large size which can be up to 100 μm in 
diameter. When osteoclasts are attached on the disrupted bone surfaces to dissolve 
bone, they form a ruffled cell membrane edges. This is done to increase the 
surface area. Then, they produce tartrate-resistant acid phosphatase which release 
hyrogen ions via the carbonic anhydrase system (H2O + CO2 → HCO3
-
 + H
+
). The 
presence of hydrogen ions lower the pH of the environment, thus increasing the 
solubility of HA crystals and lastly the organic component of bone matrix are 
removed by acidic proteolytic digestion (Liu and Webster, 2007). 
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2.3     Osteoinduction and its importance for bone healing 
  Osteoinduction is a process whereby osteogenesis is initiated. This 
mechanism of bone formation is commonly observed during the bone healing 
process.  
Bone and its surrounding osteogenic tissues contain a number of 
undifferentiated cells in addition to the differentiated bone cells such as     
osteoblasts, osteoclasts and osteocytes. These undifferentiated cells are recruited 
to form osteoprogenitor cells and they play a critical role during bone healing as 
well as during the process of osseointegration of an implant. An undifferentiated 
mesenchymal cell can be transformed into a preosteoblast, a process which 
constitutes bone induction, with the right stimulus such as the inductive agent. 
There are many studies in the past describing bone induction at various host sites 
and these authors have used gall bladder epithelium, alcohol extracts of bone and 
transplants to muscles or the anterior chamber of the eye, to demonstrate the 
formation of  heterotopic bone. A widely acceptable method to demonstrate the 
osteoinductive property of a particular agent is to inject it into a heterotopic bed 
such as a muscle pouch and subsequently analyse for any potential bone 
formation. Inductive agents naturally function in bone surroundings too. However, 
it is a challenge to differentiate between bone induction and bone conduction in an 
orthotopic site (Alberktsson and Johansson, 2002). 
 Research into osteoinduction dates back to Urist’s experiment in the mid 
1960s (Urist, 1965). In this experiment, demineralised bone was used as an 
osteoinductive agent. Later, Urist et al. (1986) managed to isolate a soluble 
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glycoprotein called bone morphogenetic proteins (BMP) as the inductive agent. 
The BMP belong to the transforming growth factor (TGF)-β-family of growth 
factor. To date, a great number of research projects had arisen from there, 
involving various types of BMP. BMP are naturally released in response to trauma 
or at bone remodelling. So far, they are the only known inductive agents. Besides 
BMP, other factors such as physical stimuli for example, stress or types of 
electrical signals otherwise applied have been regarded as, directly or indirectly, 
influencing bone induction. 
During, osteoinduction, preosteoblasts are formed by recruiting immature 
cells. This process is a basic biological mechanism that normally takes place in 
fracture healing and healing at the implant site. Although pre-existing osteoblasts 
(i.e. before injury) may assist to form new bone, these cells only contribute a 
minor portion of new bone needed in a fracture healing situation.  
According to a study by Frost (1992), injury to the bone, marrow and soft 
tissue triggers the subsequent repair. The injury releases a wide range of local, 
biochemical and biophysical mediators that stimulate these pre-osteoblastic cells. 
These mediators also play a role in the cellular differentiation and organisation of 
these cells, while others may provide mitogens. Osteoinduction starts immediately 
after the injury and this process would be very active during the first week 
thereafter, even though the action of the newly recruited preosteoblasts is not 
obvious until several weeks later, in the callus stage. However, it is a challenge to 
differentiate between bone induction and bone conduction in an orthotopic site 
(Alberktsson and Johansson, 2002). 
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             2.4 Anatomy of rabbit teeth 
Rabbits are lagomorphs with two pairs of upper incisors. The second pair of 
incisors which is often regarded as the peg teeth is small and is located 
immediately behind the larger incisors. The lower jaw of the rabbit is called the 
mandible while the upper jaw is called the maxilla. The mandible is narrower than 
the maxilla. The deciduous teeth of a rabbit are rarely seen because they are shed 
before birth or shortly after birth. Besides that, rabbits have a set of cheek teeth 
located in the back of the mouth which are used for grinding.  The cheek teeth are 
divided into upper molars and lower molars. The upper molars consist of six teeth 
with three premolars and three molars while the lower molars consist of five teeth 
with two premolars and three molars on each side (refer Figure 3.3). The physical 
structure of a rabbit’s teeth is accommodated for the ingestion of fibrous diet. The 
incisors and the cheek teeth are open rooted and they grow continuously at a fast 
rate.  The growth of the incisor has been measured at 2.0 to 2.4 mm per week. The 
rate of growth is dependent on the rate of eruption and the rate of attrition 
(Hartcourt-Brown, 2007).  
Rabbit’s teeth are cylindrical in shape. Enamel and dentine are formed 
continuously from germinal tissue at the extremity of the tooth that is buried in the 
jaw. Hence, the buried section of the tooth is eventually supragingivally exposed. 
In rabbits, enamel coats both the exposed and buried parts of the teeth and for this 
reason; there is no distinguishable root, crown, or neck. Therefore, terms such as 
anatomical crown is used to describe the whole tooth, exposed or clinical crown 
and reserve or submerged crown or clinical root is used to describe the 
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supragingival and subgingival sections. On the other hand, the terms apex, apical, 
and periapical refer to the extremity of the tooth that is embedded in the jaw 
(Hartcourt-Brown, 2007). 
 The wear against opposing teeth during mastication and chewing 
movements that rabbits make during rest help to maintain the shape of the occlusal 
surfaces of the teeth. Mastication and the occlusal relationship of the teeth in 
rabbits has been the subject of a study as early as 1958, using cinematoradiography 
to investigate the relative position and movements of the jaws. Weijs and Dantuma 
(1981) have reported that the movement of the rabbit’s jaws depends on the type of 
food that is eaten. A crushing action was used when carrots were eaten while a 
shearing action was used when hay was eaten. Both actions of crushing and 
shearing were used when pellets were eaten. These actions of the jaws are normal 
and enable rabbits to eat a wide range of food. The sharp enamel ridges on the 
cheek teeth play an important role in mastication, particularly when fibrous 
material is consumed and needs to be reduced to small particles before it is 
swallowed. The following clinical findings show that a rabbit has a good dentition 
(Harcourt-Brown, 2007): 
    Rabbits with healthy appetite and will easily eat a large amount of hay.  
    Rabbits with healthy coat. Rabbits usually use their incisors to remove   
dead hair and parasites from their coat and use their tongues to lick and 
clean the fur. Dental disease is a main differential diagnosis for a rabbit 
with unhealthy fur or heavy ectoparasite burdens. 
   Palpably smooth, straight ventral borders to the mandible. 
   Short, smooth, well-enameled incisors that occlude ordinarily. 
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   Enamel ridges that form a series of upright points along the lingual edge of 
the row of cheek teeth. The ridges can be observed during oral 
examination with an otoscope. 
 
2.5  Tissue engineering 
Tissue engineering is the state of the art in applied biomedical research 
aimed at developing procedures and new biomaterials for the fabrication of new 
tissues. These new tissues are then introduced into a patient to promote, repair or 
replace existing tissues in the body. Tissue engineering is based on principles of 
cell biology, developmental biology, and biomaterials science (Slavkin and 
Bartold, 2006).  
This approach was contrived because of constant lack of donor organs and 
tissues. It has also been expanded to rectify damaged tissues and develop newly 
improved methods in surgical procedures (Williams et al., 1999). 
 The recent progress in growth factor biology and biodegradable polymer 
constructs have been the focus for successful tissue engineering of cartilage, bone, 
and related tissues (Slavkin and Bartold, 2006). 
There is a need to exert mutual influence between three components in the 
implementation of successful tissue engineering (Slavkin and Bartold, 2006): 
 The implanted and cultured cells that will create the new tissue. 
 A biomaterial to represent a scaffold or matrix to hold the cells. 
 Biological signalling molecules that act as a guide for the cells to form the 
desired tissue type. 
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Generally, there are three well-explained approaches currently being used to 
engineer new tissue (Williams et al., 1999). They are:  
 Infusion of isolated cells or cell substitutes 
 Use of tissue-inducing materials 
 Implantation of cells seeded in scaffolds 
 
2.6 Guided bone regeneration 
 Guided bone regeneration is a specialized sub-area of tissue engineering. In 
this technique, the bony tissue regenerates and grows on or along the surface of 
host tissue guided by the structure of an implanted scaffold. The emphasis of new 
bone growth on or along the surface of the host can be gained by a variety of 
materials used as scaffolds, for example bioceramics or by the porosity of an 
implant. The criteria in selecting an appropriate scaffold implant i.e. its physical 
appearance and its fabrication, will depend on the application and implantation 
site. Scaffolds can be in various forms such as membranes, meshes, plates, screws, 
plugs, or rods.  
Some active material such as ceramics, ceramic-glasses and bioactive 
glasses are known to have osteoconductive properties. Hence, they are suitable for 
guided regeneration of bone tissue, for example in filling bone defects. They can 
also be manufactured in a different form, for example, porous form which seems to 
improve bone ingrowth and bonding. Bioceramics and glasses vary from 
biologically stable to bioactive and even bioresorbable. These materials are brittle, 
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therefore it limits their applicability. Polymers are more rigid and more flexible 
compared to ceramics. The properties of polymers can be varied to a great extend 
by modifying the structure of the polymer. Manufacture of composites of polymers 
and ceramics has been attempted because of the combination of osteoconductivity 
and stiffness of polymer to further discover a more applicable material for 
regenerating bone (Kellomaki et al., 2000). 
 
2.7 Bone substitutes 
Beside blood, bone graft is the second most common transplantation tissue. 
Bone-grafting procedures are widely used for the repair of bone defects in 
orthopaedics, neurosurgery and dentistry. Bone grafts have the ability to promote 
tissue or bone regeneration through several mechanisms. The aim of these 
procedures is to stimulate bone-healing. Other clinical applications of bone grafts 
include spinal fusions, filling of bone defects after tumour removal and bone 
augmentation procedures in congenital diseases. In general, grafts can be divided 
into four categories which are autograft, allograft, xenograft and alloplast 
(Giannoudis et al., 2005). 
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2.8 Bone graft characteristics 
2.8.1 Osteogenesis, osteoinduction and osteoconduction 
Osteogenesis, osteoinduction and osteoconduction are three important 
properties of bone regeneration in which a bone graft may possess. 
Osseointegration would be the ultimate bonding between the host bones and 
grafting material. During transplantation, osteoprogenitor cells residing within the 
donor graft, may survive and these cells have the tendency to proliferate as well as 
differentiate to osteoblasts and eventually osteocytes. These cells represent the 
osteogenic potential of the graft. Hence, osteogenesis is the process of new bone 
formation by cells from the host itself or the graft. 
Osteoinduction is the process of stimulation and activation of host 
mesenchymal stem cell from the surrounding tissue or mesenchymal stem cells 
from the graft, which subsequently differentiate into chondroblasts or osteoblasts. 
During this process, a cascade of signals is mediated along with the activation of 
several extra- and intracellular receptors. These receptors are the most important 
and they belong to the TGF-beta super-family.  
Osteoconductive graft materials may merely act as a three dimensional 
scaffold on which host bone might grow. Osteoconduction involves the facilitation 
and orientation of blood-vessel and the creation of new Haversian systems into the 
bone scaffold. This is typically followed by osseointegration, a process which 
describes the surface bonding between the host bone and the grafting material 
(Giannoudis et al., 2005).  
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These bone graft characteristics can be found in various types of bone graft 
substitutes i.e autograft, allograft, xenograft and alloplast. However, the types of 
bone graft substitutes may or may not have all these characteristics mentioned 
earlier on (Table 2.1). 
 
2.9 Types of bone graft substitutes 
 2.9.1 Autograft 
An autograft is the tissue removed from one part of the skeleton and 
transferred to a different part of the same patient. In oral surgery and implant 
dentistry, autologous bone is the gold standard of bone grafting because it 
provides optimal osteoconductive, osteoinductive, and osteogenic properties 
needed for bone regeneration. There is also no immune reaction and the 
microscopic architecture is perfectly matched. However, there are several 
disadvantages from harvesting the autologous bone, as it lengthens the overall 
surgical procedure and is usually followed by complication of residual pain.   
For most grafting purposes required with dental implants, the grafts are 
usually obtained intraorally, for example, from the extraction sockets, edentulous 
ridges, ramus, symphysis, tuberosity or the surrounding buccal plate. This 
purpose allows the surgery to stay within the mouth. Alternatively, when there is 
a shortage of bone available in the mouth or when larger grafts are required, bone 
will be transferred extraorally from other parts such as the iliac crest or tibia 
(Bashutski and Wang, 2009). 
18 
 
2.9.2 Allograft 
An allograft is defined as a bone graft between two individuals of the same 
species but is genetically dissimilar. Allograft is the most frequently chosen bone 
substitute and it is always the surgeon’s second option because of its high success 
rate. In addition, no additional surgical procedure is required to obtain bone from 
a donor site. However, the disadvantages would be the potential to transfer viral 
disease, cost and graft contamination during processing.  
Allografts can be separated into cortical or cancellous component and can 
be prepared either in fresh, frozen or freeze-dried form. Fresh allografts are hardly 
used as they might kindle an immune response or even transmit diseases. The 
commonly used allografts are freeze-dried bone allografts and decalcified freeze-
dried bone allografts. Decalcifying the bone allografts exposes the bone 
morphogenetic protein which has osteoinductive properties but this type of graft 
has a higher resorption rate compared to the freeze-dried bone allografts and thus 
has the tendency to act as a less effective scaffold (Bashutski and Wang, 2009). 
The concern regarding viral disease transmission is practically eliminated 
through tissue processing and sterilisation. Nevertheless, both freezing and 
irradiation that eliminate the cellular phase of the allograft modify the processes 
of graft incorporation and affect its structural strength. Hence, allografts might be 
osteoconductive or osteoinductive, depending on the processing method used. 
Frozen and freeze-dried allografts are more osteoconductive but are considered to 
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have a weaker osteoinductive capabilities compared to fresh allograft (Giannoudis 
et al., 2005). 
 
2.9.3 Xenograft 
Xenograft is defined as a tissue graft taken from one species and transfer 
into a different species. Bovine and porcine are common animal sources for 
intraoral bone graft substitutes.  This bone has a similar microscopic structure as 
human bone which stimulates bone growth. All organic constituents in this 
grafting material are removed during processing whereby antigenicity is no longer 
a concern. Nonetheless, xenografts are considered as osteoconductive materials.  
Immune rejection remains as the biggest challenge for this type of graft and 
the risk of transmission of animal viruses to patients have yet to be resolved. In 
addition, tissue or bone regeneration with xenografts might be uncertain 
(Bashutski and Wang, 2009). 
 
2.9.4 Alloplast 
An alloplast is a synthetically derived bone graft material not coming from 
an animal or human origin. These synthetic bone grafts possess only two 
characteristics of an ideal bone graft material which is osseointegration and 
osteoconduction. As a bone graft, this material should be biocompatible, show 
minimal fibrotic reaction, undergo remodelling and support new bone formation as 
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far as possible. Alloplast can be divided into hydroxyapatite, beta-tricalcium 
phosphate, non-ceramic, polymer or bioactive glass. 
Nevertheless, these materials demonstrated several disadvantages in clinical 
settings such as low or unpredictable resoprtion, difficulty in handling, and poor 
clinical results with inflammatory foreign body reaction occasionally (Giannoudis 
et al., 2005). 
  
Table 2.1 Characteristic of available bone graft materials and their sources 
(adapted and modified from Bashutski and Wang, 2009). 
 Types of bone graft 
Autograft Allograft Xenograft Alloplast 
Source Host Different 
individuals 
Different 
species 
Synthetic 
Properties Osteogenic Osteoinductive Some 
osteoinductive 
Osteoconductive 
Osteoinductive Osteoconductive Osteoconductive  
Osteoconductive    
 
 
2.9.4.1 Polymers 
Polymers can be either in synthetic or natural forms. They are the largest 
diverse class of biomaterials. Polymeric biomaterials are vastly used in several 
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applications, particularly medical and pharmaceutical. Their contribution to the 
quality and effectiveness of health care is greatly significant. 
 Like other materials, polymers can be available in a wide variety of 
compositions and properties. They can be produced and then processed to form 
complex shapes with different sizes according to the requirement of its final 
application. Besides that, their surface properties and fabrication can be modified 
by physical, chemical or biochemical means. This modification is important in 
biological applications. However, the main disadvantage is that some portion of 
the modified material may leach out during use, and this may cause undesirable 
effects in the host (Piskin, 2002). 
 
2.10 Biodegradable polymers 
2.10.1 Overview 
There is a great number of biodegradable polymers which can be 
synthesized by microorganisms using renewable resources. At the same time, 
microorganisms and enzymes that are capable of degrading these polymers have 
been identified. Biodegradable plastics have been developed as surgical implants in 
vascular and orthopaedic surgery as implantable matrices for the controlled long-
term release of drugs inside the body, as absorbable surgical sutures, and for use in 
the eye (Chandra and Rustgi, 1998).  
One definition of biomaterial is as a nonviable material used in medical 
device applications that is intended to interact with a biological system (Chandra 
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and Rustgi, 1998). The term biocompatibility (which deals with the tissue reaction 
to foreign materials), is defined as the ability of a particular material to perform 
with an appropriate host response in a specific application. Biomaterials are used 
for the following purposes:  
(a)  To replace tissues that are diseased or damaged such as in joint 
replacements, artificial heart valves and arteries, tooth reconstruction and 
intraocular lenses. 
(b)  To aid in repairing tissues in the form of sutures and also bone fracture 
plates, ligament and tendon repair devices. 
(c)  To substitute the entire or part of the function of the major organs, such as 
in haemodialysis (replacing the function of the kidney), oxygenation (lungs), left 
ventricular or whole heart assistance (heart), perfusion (liver), and insulin delivery 
(pancreas). 
(d)  To distribute drugs to the body via targeted sites for example, either directly 
to a tumour or sustained delivery rates (insulin, pilocarpin, contraceptives). 
 
 Plastics have become an essential and irreplaceable part of twentieth 
century life. It is difficult to degrade petrochemical plastics and because of that, 
concern over the management of this material particularly disposal of plastics has 
led to a general consensus to reduce, reuse and where possible, recycle plastic 
materials. The bacterially derived polyhydroxyalkanoate (PHA) polymers provide 
an alternative to petrochemical plastics because they have similar material 
properties but are naturally produced and are therefore biodegradable (Hammond 
and Liggat, 1995). 
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 The production of plastic polymers from renewable resources has gradually 
increased in interest and is constantly expanding because it is understood and 
apparent that fossil fuels and petrochemicals are a finite resource. Furthermore, the 
accumulation of synthetic non-degradable plastics in the environment and their 
combustion products are serious pollution problems. 
With the persistence of plastics in the environment, there has been a 
worldwide research effort to develop biodegradable polymers to overcome 
environmental pollution due to petrochemical plastics (Swift, 1992). 
Degradable polymers have found applications in a lot of areas, for example, 
in medicine such as in sutures, wound dressings, surgical implants, and controlled-
release drug delivery systems. Besides that, there is a great demand for degradable 
plastic films for use in garbage bags, food and beverage containers, and for 
mulching.  Several industries are currently developing biodegradable polymers 
for ultimate use in the consumer products. Three major requirements are 
established in order to get general acceptance of biodegradable polymers in the 
environment (Swift, 1992); 
a)  to rationalize the usage of these materials 
b)  a comprehensive explanation which  exhibit that what these materials do in 
the environment is acceptable to everyone 
c)  to implement test protocols to verify that these materials do as expected in 
the environment  
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 Degradable polymers/plastics play important roles in conserving the natural 
ecosystems i.e. to reduce the pollution and to maintain a proper balance in the 
environment. 
 
             2.10.2 Biodegradable polymer as a substitute for plastic 
Biodegradable polymer is defined as a polymer in which the degradation is 
mediated at least partially by a biological system (Li and Vert, 2002).  
 Biodegradable macromolecules can be processed specially to cater for 
controlled degradation under the inherent environmental stress in biological 
systems either unaided or by enzyme-assisted mechanisms. Progressively, it was 
realized that biodegradable systems could be of great relevance for temporary 
therapeutic applications in surgery, in pharmacology and also in tissue 
engineering. The first biodegradable synthetic polymer was poly(glycolic acid) 
which was invented in 1954. Unfortunately, this polymer was rejected because of 
its poor thermal and hydrolytic stabilities which were not suitable to be used as a 
conventional plastic material. Twenty years later, it became the first biodegradable 
suture material not related to natural polymers. From there, many studies of the 
mechanisms of biodegradation of synthetic polymers were motivated. Medical 
applications of biodegradable polymers have led to vital developments, such as the 
controlled release of drugs, fertilizers and pesticides, resorbable surgical implants, 
skin grafts and bone plates (Huang, 2002). 
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2.11 Polyhydroxyalkanoates (PHA) 
Organisms are able to accumulate large amounts of carbon and energy in 
the form of osmotically inert polymers. These polymers include polysaccharides 
such as glycogen in bacteria and animals, and starch in algae and higher plants. 
Beside polysaccharides, other highly interesting natural storage compounds like 
polyesters can be formed by bacteria (Anderson and Dawes, 1990). 
Polyhydroxyalkanoates are a group of natural polyesters that are produced 
by bacteria in the presence of excess carbon (Anderson and Dawes, 1990). They 
are one of the most fascinating and largest groups of thermoplastic polymers 
known, with over 100 different types currently produced from a variety of different 
monomer types as shown in Figure 2.1. Their properties span a wide range, 
including materials that resemble polypropylene and others that are elastomeric. 
They possess different chemical properties, either from the length of the pendant 
groups which extend from the polymer backbones, or from the distance between 
the ester linkages in the polymer backbones. The monomeric composition of PHA 
depends on the bacterial strain and on the carbon source used, for example glucose, 
during the accumulation phase (Williams et al., 1999).  
PHA can be classified as short-chain-length PHA(scl-PHA) which consists 
of 3 to 5 carbon atoms in the repeating hydroxyalkanoate units, medium-chain-
length PHA (mcl-PHA) which have 6 to 15 carbon atoms in the repeating 
hydroxyalkanoate units, and long-chain-length PHA (lcl-PHA), which have more 
than 15 carbon atoms in the repeating hydroxyalkanoate units (Jendrossek et al., 
1996).  
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Generally, PHAs with short pendant groups are hard crystalline materials, 
whereas PHAs with longer pendant groups are elastomeric. PHAs offer a wide 
range of mechanical properties and they are also biodegradable. They are broken 
down in soil and water by bacteria and fungi in the environment, in the similar way 
that plant and animal waste is degraded. Their biodegradability and the fact that 
they can be produced from renewable resources make PHA of considerable 
commercial interest for use in various industrial applications (Anderson and Wynn, 
2001). 
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           Figure 2.1   Examples of monomers that can be incorporated into PHA 
polymers (adapted from Williams et al., 1999)   
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2.11.1   PHA composition and properties 
 PHAs are linear polyesters which made up of hydroxyacid monomers. Most 
common are 3-hydroxyacid monomers and 3-hydroxyacids with carbon chain 
lengths from C3-C14 that have been identified in the range of PHA produced by 
bacteria. Most PHA comprise two or more different monomers and is known as 
heteropolymers except PHB which is a homopolymer. Generally, the polymers 
are composed of a random sequence of the constituent monomers rather than 
having different monomers in separate chains. In addition to 3-hydroxyacids, 
various other hydroxyacid monomers have been identified in PHA. The 
composition of PHA depends on the organism as well as the carbon sources 
available during polymer accumulation and research has shown that, collectively, 
bacteria are able to incorporate over a hundred different hydroxyacid monomers 
in PHA (Anderson and Wynn, 2001). Several examples of bacterial PHA are 
given in Table 2.2 
 PHA monomers are produced from ‘precursor substrates’ that have a 
related chemical structure. For example, Pseudomonas oleovarans synthesises 
PHA containing mainly 3-hydroxyoctanoate monomers from octanoic acid or 
octane, and Ralstonia eutropha produces 4-hydroxybutyrate and 3-
hydroxypropionate monomers from 4-hydroxybutyric acid and 3-
hydroxypropionic acid, respectively (Anderson and Wynn, 2001). 
 The physical properties of PHA are dependent on its constituent monomers. 
For example, PHB is hard and inflexible, but polymers with longer side chains are 
soft elastomers.  In some cases, it is easy to control the composition of PHA. 
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Therefore its physical properties can easily be controlled by altering the 
composition of the medium. For example, Ralstonia eutropha produces PHB 
from glucose and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/V) from 
glucose plus propionic acid. PHB/V is a copolymer made up of 3HB and 3HV 
monomers, and its composition can be controlled by varying the concentrations of 
glucose and propionic acid in the medium during the polymer accumulation 
phase. PHB is hard and brittle, but with the incorporation of a small proportion of 
3-hydroxyvalerate (3HV) monomers into the polymer chain, will result in a 
stronger and more flexible plastic. This is investigated and applied in the 
commercial production of PHB/V (Anderson and Wynn, 2001). 
 In some cases, bacteria can synthesize PHA monomers that have no relation 
to the structure of the carbon sources provided. For example, fluorescent 
pseudomonads produce PHA containing 3-hydroxydecanoate from many carbon 
sources and some Rhodococcus and Nocardia species produce PHB/V containing 
a high proportion of 3HV monomers, from a variety of carbon sources (Anderson 
and Wynn, 2001). 
Tan et al. (1997) used saponified palm kernel oil (SPKO) as carbon 
substrate to synthesize PHA from Pseudomonas putida. The polyester produced 
has similar properties to the derivatives of lauric and myristic fatty acid which is 
soft, flexible and transparent in presence. The synthesized PHA consist of n-
alkanoate monomers ranging from C6 -C14 with C8 as the main component of the 
material. 
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Table 2.2   Composition of PHA produced from various carbon sources by a 
range of bacteria (adapted from Anderson and Wynn, 2001) 
Organism Carbon source (s) Composition of PHA 
3-hydroxyacid monomers Other 
monomers 
C3  C4    C5    C6   C7  C8    C9  C10 C11  C12 
Ralstonia 
eutropha 
Glucose          
R. eutropha Glucose + propionic 
acid 
           
R. eutropha Glucose + 4-
hydroxybutyric acid 
          (4HB) 
Comamonas 
acidovorans 
Glucose + 4-
hydroxybutyric acid 
          (4HB) 
Alcaligenes 
latus 
Sucrose + 3-
hydroxypropionic 
acid 
     
Pseudomonas 
oleovorans 
Octanoic acid                                    
P. oloevorans Nonanoic acid                                 
P. 
aeruginosa 
Gluconic acid                                              
Rhodococcus 
ruber 
Glucose            
       principal monomer present in PHA 
       other monomers – 4HB 4-hydroxybutyrate 
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2.11.2   PHA biosynthetic pathway 
 Several different metabolic pathways for the synthesis of PHAs are known 
to occur in bacteria. There are four different pathways which have been identified 
for the synthesis and incorporation of almost all the known constituents of 
bacterial PHA (Steinbuchel, 1992). 
 First, acetyl coenzyme A (acetyl-CoA) is converted to P(3HB) via three 
enzymatic steps in A. eutrophus. A biosynthetic β-ketothiolase catalyzes the 
formation of a carbon-carbon bond of two acetyl-CoA moieties. An NADPH-
dependent acetoacetyl-CoA reductase catalyzes the reduction of acetoacetyl-CoA 
formed in the first reaction to D-(-)-3-hydroxybutyryl-CoA. The third reaction of 
this pathway is catalyzed by the PHA synthase, which links the D-(-)-3-
hydroxybutyryl-moeity to an existing polymer molecule by an ester bond.  
The second type is the five-step PHA biosynthetic pathway in a 
photosynthetic bacterium, Rhodospirillim rubrum. Acetoacetyl-CoA formed by 
the β-ketothiolase is reduced by an NADH-dependent reductase to L-(+)-3-
hydroxybutyryl-CoA. The latter is then converted to the D-(-)-3-hydroxybutyrul-
CoA by two enoyl-CoA hydratases. The last step of this pathway is again the 
polymerization catalyzed by the PHA synthase. 
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Figure 2.2   Metabolic pathway for the production of short-chain-length PHA  
 in Ralstonia eutropha (adapted from Romano, 2002) 
 
 The third type of PHA-biosynthetic pathway seems to be active in most 
pseudomonads belonging to the ribosomal RNA homology group I. In this 
pathway, the intermediates from the β-oxidation of the activated fatty acids 
derived from alkanes, alkanols, or alkanoates are directed to PHA biosynthesis. 
For example, Pseudomonas oleovorans accumulates polyester that contains 3-
hydroxyactanoate and 3-hydroxyhexanoate as the main constituents when 
cultivated on octane, octanol or octanoate. 
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 The fourth type of pathway is found in almost all pseudomonads belonging 
to the rRNA homology group I, except P. oleovorans. Copolymers consisting of 
medium-chain-length 3-hydroxyalkanoates are synthesized from acetyl-CoA. The 
precursors for PHA synthesis are derived from de novo fatty acid synthetic 
pathways. The biosynthesis of PHA mainly consisting of 3-hydroxydecanoate in 
Pseudomonas aeruginosa follows this pathway (Lee and Choi, 1999). 
Figure 2.2 exhibit a typical example of biosynthetic pathway for the 
production of scl-PHA in Ralstonia eutropha (Romano 2002). 
 
2.11.3   Biodegradation of PHA 
 Several parameters that can influence the rate of biodegradation of PHA are 
the type of environment, microbial population, the availability of water or 
moisture, temperature, the shape and thickness of the plastic material, surface 
texture, porosity and crystallinity, and the presence of other components in the 
plastic, such as fillers or colouring agents. 
 Methods that determine the degradability of plastic materials are usually 
based in direct visual observation of plastic material, quantitative determination of 
microbial growth on plastic material (measured by turbidity or protein and 
phospholipids content), polymer utilization by micro organisms (by gravimetric 
or visual observation), determination of changes in polymer characteristics during 
incubation (by tensile strength or molecular weight), and determination of 
microbial activities such as titrimetric, electrochemical, or monometric activities. 
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Field or in situ experiments in which the samples are placed in the desired 
environments are required for the determination of biodegradability; because 
these laboratory test methods (as written above) are difficult to employ in the 
natural environment (Lee and Choi, 1999). 
 In aerobic conditions, PHA is degraded into carbon dioxide and water while 
in anaerobic conditions; it is finally degraded into methane, water and carbon 
dioxide. Degradation of P(3HB) occurs in to steps. First, P(3HB) is degraded into 
3HB oligomers, preferentially 3HB dimmers, by the extracellular P(3HB) 
depolymerase. Secondly, an oligomer hydrolase cleaves the dimmer into 3HB 
monomer. A number of aerobic and anaerobic PHA-degrading bacteria and fungi 
have been isolated, and the extracellular PHA depolymerises from several 
bacteria have been cloned and characterized (Lee, 1996). 
Ho et al. (2002) reported that mcl-PHA was degraded in tropical river water 
with a weight loss of 71.3 % of the PHA film in 86 days. Shorter-chain monomers 
in mcl-PHA were selectively removed from the PHA molecule which suggested 
enzymatic action. On the other hand, Lim et al. (2005) reported the 
biodegradation of similar mcl-PHA film in tropical forest and mangrove soils. 
There was weight loss in the test material and the degradation was by surface 
erosion. However, the integral properties of the films were maintained. 
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2.11.4   Applications and commercial aspects of PHAs 
 PHAs have been drawing considerable industrial interest as candidates for 
the biodegradable and biocompatible plastics and elastomers for a wide range of 
applications, including packaging, controlled drug release and biomedical 
materials (Lee and Choi, 1999). 
 Besides that, mcl-PHAs can also be used in a number of applications, for 
example, elastomeric (rubber-like) materials, cheese coating, adhesives, coatings 
and paint binders. The massive exploitation of PHAs in tissue engineering has 
been reported in several medical applications; or as stocks for the stereoscopic-
drug industry (Romano, 2002). 
 The bacterium Ralstonia eutropha accumulates scl-PHA, which can be 
processed and applied in a way similar to commodity plastics. The heteropolymer 
PHB / HV is commercially known as Biopol
TM
. Biopol
TM
 can be processed on 
most types of conventional thermoplastic melt-processing equipment. Examples 
of product forms include a wide range of injection-moulded products and 
extrusion blow-moulded bottles. Foamed products can also be produced. In 
addition to the properties and processes associated with conventional 
thermoplastics, the Biopol
TM 
resins offer additional features of naturalness and 
biodegradability. The fermentation production process and the use of renewable 
feedstock clearly differentiate these products from conventional petrochemically 
derived plastics. Biodegradability expands the range of disposal options. In 
addition to conventional waste management routes such as recycling and 
incineration, these materials have benefits in products which may be disposed in 
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sewage systems, the soil or managed landfill sites. The disposable hygiene and 
agricultural markets fit into this category.  
 On the other hand, medical applications can exploit the key features of 
biocompatibility and relatively slow in vivo biodegradation reported for Biopol
TM 
polymers. There is evidence in experiments suggesting that Biopol
TM
 resins are 
extremely well tolerated when implanted within the body. The Biopol
TM
 implant, 
however, was completely biodegraded and the resulting repaired pericardium 
tissue gave far fewer postoperative adhesions compared to control experiments 
(Hammond and Liggat, 1995). 
 
2.11.5   Applications of PHAs in medicine 
At present, PHA and its composites are thought to have high potentials as 
apparent materials for medical devices such as sutures, bone plates, surgical mesh 
and cardiovascular patches and many more (Table 2.3). A recent major 
advancement for this group of biomaterial is the clearance acquired from the Food 
and Drug Administration of the United States of America for the use of P(4HB)-
derived TephaFLEX
® 
 as absorbable sutures (Ying et al., 2008). 
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Table 2.3   Potential applications of PHA in medicine (adapted from Zinn et 
al., 2001). 
 
Type of application Products 
Wound management Sutures, skin substitutes, nerve cuffs, surgical 
meshes, staples, swabs 
 
Vascular system Heart valves, cardiovascular fabrics, pericardial 
patches, vascular grafts 
 
Orthopaedy Scaffolds for cartilage engineering, spinal 
cages, bone graft substitutes, 
meniscus regeneration, internal fixation devices 
(e.g., screws) 
 
Drug delivery Micro- and nanospheres for anticancer therapy 
 
Urology Urological stents 
 
Dental Barrier material for guided tissue regeneration 
in periodontitis 
 
Computer assisted tomography and 
ultrasound imaging 
Contrast agents 
 
 
 
 Because they are bioabsorbable and biocompatible, PHAs are particularly 
interesting. The metabolism and excretion of some monomers incorporated into 
PHA are well understood. For example, the monomeric component of P(3HB), 
(R)-3-hydroxybutanoic acid (3HB), is a ketone body which exist at concentrations 
of 3 - 10 mg per 100 ml blood in healthy adults (Williams and Martin, 2002). The 
monomeric component of P(4HB), 4-hydroxybutanoic acid (4HB), can also be 
located in various organs and it is widely distributed in the brain, kidney, heart, 
liver, lung and muscle of the mammalian body (Nelson et al., 1981). Moreover, 
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the hydroxyl acids liberated during PHA in vivo breakdown are reported to be 
considerably less acidic and less inflammatory compared to many other synthetic 
absorbable polymers such as poly(lactic acid) (PLA) (Taylor et al., 1994). 
Nevertheless, P(3HB) has limited application due to its properties such as high 
brittleness, poor process ability and slow degradation. Therefore, researchers in 
this field of interest had shown great progress over the past 20 years and it is now 
possible to design and synthesize various kinds of PHA  to further improve the 
inferior properties of P(3HB) (Ying et al., 2008). 
Quite a number of applications were proposed, tested and then applied in 
medicine. For example, PHBV is non-toxic and compatible with living cells, 
producing an extremely moderate foreign body response and the biodegradation 
rate in vivo is low. The main degradation product for PHBV is R-β-hydroxy-
butyric acid, which is typical metabolite that can be found in mammalian cells. 
Controlled drug release microcapsules, surgical sutures, surgical swabs, wound 
dressings, lubricating powder for surgeon’s gloves and even blood-compatible 
membranes are common applications that can be quoted for consideration in 
hospitals. One of the advantages of using PHB or PHBV is that unlike cotton, 
small pieces of these materials such as from swab or dressing can be left in the 
wound without the risk of inflammation (Chodak, 2002).  
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2.11.5.1 PHA as drug carrier 
PHAs have been used as drug carriers due to their biodegradability and 
biocompatibility as early as in the 1990s (Pouton and Akhtar, 1996). For example, 
microspheres of PHB loaded with rifampicin were investigated for their use as a 
chemoembolizing agent (Kassab et al., 1997). It was reported in this study that 
the drug release of all microspheres was very fast. Almost 90 % of the drug was 
released within 24 hours. Hence, it was possible to control the drug release rate by 
the drug loading and the particle size (Zinn et al., 2001). 
Also the usage of PHA as an antibiotic-loaded carrier to treat implant-
related and chronic osteomyelitis was investigated by Yagmurlu et al. (1999). In 
this study, sulbactamcefoperazone, a type of antibiotic, was  integrated into rods 
(1 × 0.3 × 0.3 cm
3
; 100 mg) made of poly(3-hydroxybutyrate-co–22 mol%-3-
hydroxyvalerate) and implanted into a rabbit’s tibia that was artificially infected 
by S. aureus. After fifteen days, the infection subsided and almost complete 
healing was found on the thirtieth day.  
All the mentioned examples show that the release of drugs from 
microspheres made of scl-PHA occurs at excessive rates. One of the reasons of 
this effect may be due to the manufacturing process, for example, the level of 
porosity. However, it can be hypothesize about that PHAs with a lower 
crystallinity, for example mcl-PHA would be a better candidate used for granules 
with lower drug release rates. Yet, because of the low availability of mcl-PHA, 
such research is still limited (Zinn et al., 2001). 
 
 
40 
 
2.11.5.2 PHA as scaffold material in tissue engineering 
A study done by Williams et al. (1999) has defined five parameters that 
scaffolds need to fulfil for successful tissue engineering: They are: 
(1) biocompatibility  
(2) support for cell growth and cell adhesion 
(3) guide and organize the cells 
(4) allow ingrowth of cells and passage of nutrients and waste products,  
(5) biodegradable without forming toxic compounds 
  
In tissue engineering, PHA scaffolds can be implanted together with the 
supporting scaffold. This approach was exemplified by Sodian et al. (2000) that 
used scl-PHA for the fabrication of a tri-leaflet heart valve scaffold. 
DegraPol, a block-copolyesterurethane, chemically synthesized from PHB-
diol and α,ω-dihydroxy- poly(Є-caprolactone-block-diethylene-glycol-block-Є-
caprolactone), showed a good biocompatibility in vivo and in vitro (Saad et al., 
1999). The results in this study reported that the degradation products of a 
DegraPol foam are well phagocytized by macrophages and osteoblasts. However, 
at high concentrations of low molecular weight PHB (Mn ~ 2300) cell viability of 
macrophages and to a lesser extent of osteoblasts was reduced (Saad et al., 1999). 
This study suggested that DegraPol is useful in bone healing processes, for 
example, in autologous osteoblast or chondrozyte transplantation (Zinn et al., 
2001). 
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2.11.6  Biocompatibility of PHAs 
The definition of biocompatibility is substantial and it covers all the 
responses ranging from the biological system to the biomaterial. If a certain 
material is not biocompatible, it may be rejected at once or may cause other 
important problems, such as emboli, tissue necrosis or even tumour formation. 
The implant of materials in tissues always generates a response. The main 
tissue response in the extravascular system is the inflammatory process, which 
starts off as a local reaction to injury, insult or infection. Inflammation may be 
induced biologically, chemically or physically. This complex process involves 
many proteins and cells. Indirectly, the chemical characteristics of a biomaterial, 
in the long-term, the released substances and the biodegradation products, may be 
responsible for foreign body reactions. If the foreign body reaction in soft tissue 
to a biomaterial is a mild inflammatory response, healing may occur quickly, and 
eventually, the implant will perform effectively (Piskin, 2002).  
In addition, cell attachment, spreading, and growth are important criteria to 
evaluate the biocompatibility of a biomaterial. These processes are influenced by 
certain factors i.e. the various types of surface composition, surface free energy 
and morphology. The process of cell attachment normally takes place in two 
steps. Initially, the random cell adhesion would occur on the surface of 
biomaterial, which is mainly governed by physical and chemical interaction 
between the biomaterial and cells. This is followed by specific cell adhesion on 
the surface (Li et al., 2005). 
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If a medical application is being considered, it is of no uncertainty that the 
biological response to PHA polymers in vivo is the most important property of 
these biomaterials (Williams and Martin, 2002). 
In vitro tests have shown that polyhydroxybutyrate (PHB) is biocompatible 
to various cell lines which include osteoblastic, epithelial cell and ovine 
chondrocytes (Rivard et al., 1996; Nebe et al., 2001). The latest research yielded 
a good advancement in order to evaluate the biocompatibility of an implanted 
material by investigating the structural alterations in cellular molecules that are 
involved in cell adhesion when cells were cultured on PHB (Nebe et al., 2001). 
Besides that, Rivard et al. (1996) reported that when a highly porous well-
interconnected PHBV structure was seeded with fibroblasts, it kept the rate cell 
proliferation similar to that observed in collagen sponges for 35 days, with a 
maximum cell density being noted on the twenty-eighth day. Nonetheless, the 
polymers have also resulted in both prolonged acute inflammatory responses and 
chronic inflammatory responses (Akhtar, 1990).  
It is worth noting that, in vivo, when most PHA polymers break down, they 
release hydroxyl acids that are less acidic and less inflammatory compared to 
many currently used synthetic absorbable polymers (Williams and Martin, 2002).  
 
2.12  Production of PHAs using saponified palm kernel oil as a carbon 
substrates  
Oil palm (Elaeis guineensis Jacq) is a perennial monocot belonging to the 
family Palmae and tribe Cocoineae. It gives the highest oil yield per hectare of all 
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the economic oil crops (Corley and Tinker, 2003). It is an important crop for 
Malaysia and has great contributioin to the national economy as Malaysia is one 
of the main exporters for palm oil (Yusof, 2002). Diversified uses for palm oil are 
constantly sought such as the conversion of palm oil into high-value and versatile 
products. Tan et al. (1997) had shown that saponified palm kernel oil was able to 
support cell growth of Pseudomonas putida and the production of mcl-PHA. An 
integral aspect in the production of this material using SPKO as carbon substrates 
is to study its potential use in the maxillofacial fixation and its potential as a bone 
substitute. 
 
2.13  Objectives of study 
Clinical problems requiring bone regeneration in oral and maxillofacial 
region are diverse and challenging. These bone-related problems usually require 
substantial bone grafting surgeries. For example, mandibular fractures and 
osteotomies have been previously managed with biologically stable metal devices 
and recently with biodegradable devices. Besides that, guided bone regeneration 
using the non-degradable membrane is still often applied in the treatment of 
periodontisis. Stiff non-biodegradable implants may cause osteopenia, cortical 
porosis, and atrophy of the underlying bone, at least in diaphyseal bone.  
Therefore, there is a necessity to remove these metal or non-degradable implants 
in order to prevent the high possibility of infection and weakening of bone which 
will lead to a possibility of refracture. Biodegradable implants can accommodate 
the effective processes of bone healing. Over time, the entire material is expected 
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to disappear completely because of degradation, and thus no secondary surgery is 
required (Ueda and Tabata, 2003). 
As mentioned earlier, PHA and its composites are thought to have good 
potentials as emerging materials in the medical field for example, to be used as 
suitable scaffolds in tissue engineering. Most of the research was focused on 
medical applications of scl-PHA due to its higher crystallization rates and the 
similar properties to polypropylene (Zinn et al., 2001), as compared to the mcl-
PHA, which may be due to the limited availability of mcl-PHA.  
In my research, the mcl-PHA which was produced by bacteria using SPKO 
as carbon substrates was used to investigate its possible osteoconductive 
properties in bone using rabbit mandible as the experimental model. The 
emphasis would be to investigate its   potential to be used as a substitute for bone 
graft in oral and maxillofacial region. Therefore, the objectives in this research 
are as follows: 
 To compare the percentage of bone fill in the bony defect with mcl-
PHA membrane in comparison to the empty defect. 
 To evaluate the quality and quantity of the bone regeneration with 
the mcl-PHA using histomorphometry. 
 To determine the biocompatibility of the mcl-PHA in terms of the 
response of host tissue. 
  
